PERCEPTIVE ADVISORS LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$6.8B
Holdings
126
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (126 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 3,435,575 | $570.5B | 8328.65% | |
| 2 | TVTX 2.5 09/15/25RETROPHIN INC | 45,000,000 | $390.1B | 5695.52% | |
| 3 | AM6AMICUS THERAPEUTICS INC | 25,122,048 | $354.7B | 5178.76% | |
| 4 | IOVAIOVANCE BIOTHERAPEUTICS INC | 10,085,632 | $332.0B | 4847.29% | |
| 5 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 5,800,996 | $319.9B | 4669.88% | |
| 6 | BBIOBRIDGEBIO PHARMA INC | 6,706,268 | $251.6B | 3673.50% | |
| 7 | CYTK 4 11/15/26CYTOKINETICS INC | 9,770,000 | $218.3B | 3187.07% | |
| 8 | —ZYMEWORKS INC | 4,400,999 | $205.0B | 2992.87% | |
| 9 | —MYOKARDIA INC | 1,395,017 | $190.2B | 2776.57% | |
| 10 | SWTXSPRINGWORKS THERAPEUTICS INC | 3,481,148 | $165.9B | 2422.72% | |
| 11 | —COLLEGIUM PHARMACEUTICAL INC | 17,500,000 | $163.8B | 2390.88% | |
| 12 | ATNXEURATHENEX INC | 13,532,467 | $161.3B | 2355.23% | |
| 13 | VAC2USDVBI VACCINES INC | 55,042,465 | $157.4B | 2298.26% | |
| 14 | NBIXNEUROCRINE BIOSCIENCES INC | 1,548,715 | $148.9B | 2174.21% | |
| 15 | OMGBPOUTSET MED INC | 2,847,822 | $142.4B | 2078.83% | |
| 16 | NVRO 2.75 04/01/25NEVRO CORP | 9,000,000 | $141.8B | 2070.52% | |
| 17 | NVROEURNEVRO CORP | 826,164 | $115.1B | 1680.18% | |
| 18 | CRSPCRISPR THERAPEUTICS AG | 1,341,308 | $112.2B | 1637.87% | |
| 19 | RLAYRELAY THERAPEUTICS INC | 2,329,407 | $99.2B | 1448.40% | |
| 20 | MGTXMEIRAGTX HLDGS PLC | 6,433,277 | $85.2B | 1243.52% | |
| 21 | —QUOTIENT LTD | 16,200,818 | $83.3B | 1215.73% | |
| 22 | BDQMALBIREO PHARMA INC | 2,360,139 | $78.8B | 1149.82% | |
| 23 | —IMMUNOMEDICS INC | 912,140 | $77.6B | 1132.32% | |
| 24 | NVV1NOVAVAX INC | 707,715 | $76.7B | 1119.50% | |
| 25 | CHRSCOHERUS BIOSCIENCES INC | 3,636,485 | $66.7B | 973.68% | |
| 26 | —FREQUENCY THERAPEUTICS INC | 3,256,518 | $62.6B | 913.31% | |
| 27 | —FORMA THERAPEUTICS HLDGS INC | 1,250,000 | $62.3B | 909.55% | |
| 28 | KODKODIAK SCIENCES INC | 1,043,021 | $61.8B | 901.62% | |
| 29 | 2L9BLUEPRINT MEDICINES CORP | 664,574 | $61.6B | 899.41% | |
| 30 | —KADMON HLDGS INC | 15,711,334 | $61.6B | 899.15% | |
| 31 | —RETROPHIN INC | 3,240,112 | $59.8B | 873.22% | |
| 32 | NARIUSDINARI MED INC | 848,500 | $58.6B | 854.99% | |
| 33 | —ATHIRA PHARMA INC | 3,114,805 | $57.5B | 839.45% | |
| 34 | CRNXCRINETICS PHARMACEUTICALS IN | 3,659,381 | $57.3B | 837.16% | |
| 35 | PRVBUSDPROVENTION BIO INC | 4,265,711 | $54.7B | 799.01% | |
| 36 | RCKTROCKET PHARMACEUTICALS INC | 2,189,010 | $50.0B | 730.57% | |
| 37 | IMVTIMMUNOVANT INC | 1,400,000 | $49.3B | 719.26% | |
| 38 | —AGILE THERAPEUTICS INC | 15,919,925 | $48.4B | 706.57% | |
| 39 | ARNAEURARENA PHARMACEUTICALS INC | 625,129 | $46.8B | 682.57% | |
| 40 | ALDXALDEYRA THERAPEUTICS INC | 6,285,458 | $46.6B | 679.97% | |
| 41 | ALLOALLOGENE THERAPEUTICS INC | 1,143,790 | $43.1B | 629.70% | |
| 42 | COLLCOLLEGIUM PHARMACEUTICAL INC | 2,058,068 | $42.8B | 625.57% | |
| 43 | PCVXVAXCYTE INC | 850,000 | $42.0B | 612.78% | |
| 44 | —NEPTUNE WELLNESS SOLUTIONS I | 19,436,906 | $41.0B | 598.75% | |
| 45 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 830,000 | $40.4B | 589.28% | |
| 46 | ADMAADMA BIOLOGICS INC | 16,584,802 | $39.6B | 578.69% | |
| 47 | —VYNE THERAPEUTICS INC | 22,876,410 | $38.0B | 554.41% | |
| 48 | CMPSCOMPASS PATHWAYS PLC | 1,047,404 | $36.6B | 533.67% | |
| 49 | LYRALYRA THERAPEUTICS INC | 3,222,561 | $36.0B | 525.99% | |
| 50 | SILKSILK RD MED INC | 520,100 | $35.0B | 510.34% | |
| 51 | RNAAVIDITY BIOSCIENCES INC | 1,235,818 | $34.8B | 507.89% | |
| 52 | —EIDOS THERAPEUTICS INC | 686,922 | $34.7B | 506.75% | |
| 53 | ZNTLZENTALIS PHARMACEUTICALS INC | 1,050,003 | $34.3B | 501.13% | |
| 54 | MGNXMACROGENICS INC | 1,291,181 | $32.5B | 474.85% | |
| 55 | —TURNING POINT THERAPEUTICS I | 329,890 | $28.8B | 420.74% | |
| 56 | BIIBBIOGEN INC | 100,000 | $28.4B | 414.16% | Call |
| 57 | —MOLECULAR TEMPLATES INC | 2,474,133 | $27.0B | 394.45% | |
| 58 | —FUSION PHARMACEUTICALS INC | 2,235,983 | $26.9B | 392.39% | |
| 59 | IMTXIMMATICS N.V | 2,500,000 | $26.5B | 387.25% | |
| 60 | VRCAVERRICA PHARMACEUTICALS INC | 3,410,412 | $26.4B | 385.38% | |
| 61 | GONGERON CORP | 13,461,538 | $23.4B | 341.96% | |
| 62 | STOKSTOKE THERAPEUTICS INC | 671,978 | $22.5B | 328.56% | |
| 63 | XBISPDR SER TR | 200,000 | $22.3B | 325.36% | Put |
| 64 | —UROVANT SCIENCES LTD | 2,366,831 | $22.1B | 322.74% | |
| 65 | —THERAPEUTICS ACQUISITION COR | 1,500,000 | $21.6B | 314.91% | |
| 66 | PMVPPMV PHARMACEUTICALS INC | 605,556 | $21.5B | 313.84% | |
| 67 | WVEWAVE LIFE SCIENCES LTD | 2,500,000 | $21.2B | 309.87% | |
| 68 | CNCEEURCONCERT PHARMACEUTICALS INC | 2,150,641 | $21.1B | 308.33% | |
| 69 | OPHTEURIVERIC BIO INC | 3,481,431 | $19.6B | 286.66% | |
| 70 | —UNUM THERAPEUTICS INC | 7,955,000 | $18.6B | 271.77% | |
| 71 | VRNAVERONA PHARMA PLC | 2,888,889 | $18.0B | 263.18% | |
| 72 | CTMXCYTOMX THERAPEUTICS INC | 2,577,043 | $17.1B | 250.19% | |
| 73 | LPTXEURLEAP THERAPEUTICS INC | 8,476,496 | $16.8B | 245.02% | |
| 74 | —MYLAN N.V | 1,004,419 | $14.9B | 217.46% | |
| 75 | HRMYHARMONY BIOSCIENCES HLDGS IN | 435,377 | $14.8B | 215.47% | |
| 76 | —DICERNA PHARMACEUTICALS INC | 800,000 | $14.4B | 210.12% | |
| 77 | SLDBSOLID BIOSCIENCES INC | 6,749,803 | $13.7B | 200.04% | |
| 78 | AMWLAMERICAN WELL CORP | 455,000 | $13.5B | 196.89% | |
| 79 | MORFMORPHIC HLDG INC | 487,000 | $13.3B | 194.38% | |
| 80 | ESTAESTABLISHMENT LABS HLDGS INC | 678,633 | $12.6B | 183.59% | |
| 81 | PPHVANECK VECTORS ETF TR | 200,000 | $12.4B | 181.53% | Put |
| 82 | —DBV TECHNOLOGIES S A | 6,806,975 | $11.8B | 171.92% | |
| 83 | ACCDEURACCOLADE INC | 293,138 | $11.4B | 166.35% | |
| 84 | HOLXHOLOGIC INC | 170,000 | $11.3B | 164.97% | |
| 85 | HCATHEALTH CATALYST INC | 291,084 | $10.7B | 155.54% | |
| 86 | —SC HEALTH CORP | 1,000,000 | $10.6B | 154.75% | |
| 87 | TSHATAYSHA GENE THERAPIES INC | 470,440 | $10.5B | 153.85% | |
| 88 | TARAPROTARA THERAPEUTICS INC | 608,544 | $10.2B | 149.53% | |
| 89 | PODDINSULET CORP | 37,733 | $8.9B | 130.33% | |
| 90 | ATRCATRICURE INC | 216,449 | $8.6B | 126.08% | |
| 91 | VRAYQVIEWRAY INC | 2,451,748 | $8.6B | 125.28% | |
| 92 | AMRSEURAMYRIS INC | 3,333,332 | $8.6B | 125.09% | |
| 93 | TWSTTWIST BIOSCIENCE CORP | 112,756 | $8.6B | 125.06% | |
| 94 | AQSTAQUESTIVE THERAPEUTICS INC | 1,750,000 | $8.5B | 124.04% | |
| 95 | —TCR2 THERAPEUTICS INC | 400,000 | $8.1B | 118.66% | |
| 96 | DYNDYNE THERAPEUTICS INC | 400,000 | $8.1B | 117.91% | |
| 97 | —1LIFE HEALTHCARE INC | 279,844 | $7.9B | 115.86% | |
| 98 | RVMDREVOLUTION MEDICINES INC | 224,224 | $7.8B | 113.92% | |
| 99 | —LONGVIEW ACQUISITION CORP | 700,000 | $7.1B | 103.73% | |
| 100 | PSTXUSDPOSEIDA THERAPEUTICS INC | 787,745 | $7.0B | 102.01% |
Page 1 of 2Next